Overview

Liver tumors may originate in the liver or spread there from cancers elsewhere in the body. Because the liver plays a central role in overall health, treatment often requires a coordinated approach involving oncology, surgery, hepatology, and interventional radiology.

For select patients, image-guided therapies can deliver treatment directly to tumors in the liver while limiting exposure to the rest of the body.

ELMNT IR offers advanced liver-directed therapies designed to support precise, coordinated cancer care in an outpatient interventional setting when appropriate.

Symptoms of Liver Tumors

Some liver tumors cause few symptoms early and are found during imaging or cancer surveillance. When symptoms occur, they may include:

• Abdominal pain or fullness
• Unexplained weight loss
• Fatigue
• Loss of appetite
• Nausea
• Jaundice in some cases
• Abnormal liver tests or imaging findings

Symptoms vary based on tumor type, tumor burden, liver function, and overall health.

When to Seek Treatment

Patients with known or suspected liver tumors should be evaluated promptly to determine the appropriate treatment pathway.

Treatment may be considered when:

• Tumors are liver-dominant
• Surgery is not recommended or not currently possible
• Local tumor control is needed
• Liver-directed therapy may support a broader oncology plan
• A patient is being evaluated for staged or combination treatment

How Liver Tumors are Diagnosed

Diagnosis and treatment planning may involve:

• CT, MRI, ultrasound, or PET imaging
• Blood tests, including liver function testing
• Tumor markers when appropriate
• Biopsy in select cases
• Multidisciplinary review with oncology and other specialists

ELMNT IR works closely with referring physicians to ensure liver-directed therapy is considered in the context of the patient’s overall cancer care plan.

Treatment Options

Treatment depends on tumor type, location, liver function, stage of disease, and overall goals of care. Options may include:

• Surgery in select cases
• Systemic therapy, including chemotherapy, immunotherapy, or targeted therapy
• Ablation for certain tumors
• Transarterial chemoembolization, or TACE
• Y-90 radioembolization, also called TARE
• Other liver-directed embolization approaches

A Minimally Invasive Option

For appropriate patients, Y-90 Radioembolization, also called Transarterial Radioembolization (TARE), delivers targeted radiation through the blood vessels feeding liver tumors.

Key advantages:

• Minimally invasive, catheter-based treatment
• Delivers therapy directly to liver tumors
• Can be integrated into a broader oncology plan
• May help control liver-dominant disease
• Often avoids open surgery

👉 Learn more about Y-90 Radioembolization (TARE) 

Who is a Candidate

You may be a candidate for liver-directed therapy if:

• You have liver cancer or liver-dominant tumors
• Surgery is not the best option
• Your oncology team recommends local tumor control
• Your liver function and vascular anatomy support treatment
• Imaging confirms disease that may be appropriate for radioembolization

A consultation, imaging review, and coordination with the oncology team are required to determine candidacy.

Why ELMNT IR

ELMNT IR is designed to bring advanced interventional radiology procedures into a more accessible, patient-centered setting while maintaining close coordination with referring specialists.

• Specialized focus on image-guided therapies
• Experience with embolization-based cancer treatments
• Streamlined referral and scheduling process
• Coordination with oncology and referring physicians
• Outpatient environment designed for comfort and efficiency

Next Steps

If you have been diagnosed with liver cancer or liver tumors, your physician can help determine whether liver-directed therapy should be part of your treatment plan.

📩 Request a consultation or speak with your oncology team about referral to ELMNT IR.